Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 9.56% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.71
Flat results in Sep 25
Risky - Negative EBITDA
Stock DNA
Pharmaceuticals & Biotechnology
INR 50 Cr (Micro Cap)
NA (Loss Making)
53
0.00%
-0.01
-0.10%
0.49
Total Returns (Price + Dividend) 
Rajnish Wellness for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Rajnish Wellness Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week and all-time low of Rs.0.48 today, marking a significant downturn in its stock performance amid a series of declines over the past week.
Read More
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 January 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.
Read More Announcements 
Closure of Trading Window
26-Dec-2025 | Source : BSEIntimation of Closure of Trading Window.
Expansion Of Medical Franchise Network
22-Dec-2025 | Source : BSERajnish Wellness Limited is please to inform about its continued expansion in the Pharmaceuticals and healthcare distribution segment through its medical franchise brand Dava Discount.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
05-Dec-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dealmoney Commodities Pvt Ltd
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Rajnish Wellness Ltd has announced 1:2 stock split, ex-date: 10 Jan 23
Rajnish Wellness Ltd has announced 2:1 bonus issue, ex-date: 21 Jul 22
Rajnish Wellness Ltd has announced 19:30 rights issue, ex-date: 03 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.43%)
Rajnish Kumar Singh (9.16%)
Dealmoney Commodities Private Limited (4.24%)
79.89%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 163.16% vs -20.97% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -72.73% vs 147.83% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024
Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -12.05% vs 153.47% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -32.00% vs -47.92% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -36.67% vs 206.35% in Mar 2024
YoY Growth in year ended Mar 2025 is -83.50% vs 123.91% in Mar 2024







